Guangzhou Baiyunshan Hanfang Reliable MCT Supplier for Chinese Pharmaceutical Excipients

Certified Medium Chain Triglycerides for Pharma, Nutraceutical & Special Medical Food Industries

【Guangzhou, China】– 2026 – Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., a leading provider of high-end pharmaceutical lipid excipients and health products, today highlights its medium chain triglycerides (MCT) as a trusted domestic supply solution for Chinese pharmaceutical excipient needs. This domestically produced MCT addresses the core pain point of stable supply for pharmaceutical, functional food and special medical food manufacturers, featuring international certifications, green production technology and customizable services. The product has been widely adopted by over 1,000 global clients, including leading pharmaceutical enterprises such as B. Braun Company and AstraZeneca.

Core Technological Breakthroughs & Product Highlights

Guangzhou Baiyunshan Hanfang’s MCT serves as a raw material, solvent and emulsifier, providing a stable domestic alternative to imported excipients. The company has developed an integrated green production technology combining supercritical CO₂ extraction, membrane separation and chromatography, replacing traditional polluting processes to ensure product purity and environmental sustainability. This technology has enabled the company to break long-term international monopolies in high-end pharmaceutical lipid excipients, increasing the localization rate of such products from 10% to 90% in China.

Global Compliance & Certifications

To meet global market access requirements, the company’s MCT and other pharmaceutical excipients have obtained multiple international certifications, including EU CEP, US FDA US-DMF, Mexico Cofepris and India DCGI. Guangzhou Baiyunshan Hanfang is also recognized as a National Specialized, Sophisticated, Unique and New "Little Giant" Enterprise and a National Green Factory, with a National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, the only national-level engineering research center in the field of pharmaceutical lipids.

Supply Information & Customization Services

Guangzhou Baiyunshan Hanfang’s MCT is available through sales offices and authorized distributors across 31 provinces, municipalities and autonomous regions in China, as well as global distribution networks covering over 20 countries and regions. The company offers a composite business model including direct sales, agency distribution, custom processing and technical services, providing tailored solutions to meet diverse client needs.

Authoritative Quotes

"Our medium chain triglycerides represent a key milestone in breaking international monopolies in high-end pharmaceutical excipients," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. "By leveraging our green production technologies, we ensure stable, high-quality supply for domestic and global clients, supporting the security of the pharmaceutical industry chain."

Industry Background & Corporate Strategy

Against the backdrop of growing demand for domestic high-end pharmaceutical excipients driven by the global pharmaceutical industry’s development and localization trends, Guangzhou Baiyunshan Hanfang focuses on independent technological innovation to address "bottleneck" issues and ensure the security of China’s pharmaceutical supply chain.

Future Plans

Looking ahead, Guangzhou Baiyunshan Hanfang will continue to deepen its focus on high-end pharmaceutical lipid excipients, increase R&D investment, and expand its global marketing and service network to provide localized support for clients in more countries and regions. The company aims to achieve double-digit growth in revenue and profit in 2026 as part of its development roadmap.

About Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.

Founded in 1998, Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. is a state-controlled enterprise under the Guangzhou Pharmaceutical Holdings (GPHL) Group, specializing in high-end pharmaceutical lipid excipients, characteristic anti-tumor raw materials, Ganoderma health products and modern traditional Chinese medicine technologies. The company operates a production base in Conghua, Guangzhou, and R&D centers in Haizhu, Guangzhou and Hengqin, Zhuhai, with over 240 patents and products sold in more than 20 countries and regions. Its mission is to achieve technological self-reliance, break "bottleneck" problems and safeguard the security of the pharmaceutical industry chain.

Contact Information

Company: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. All rights reserved.